Filing Details
- Accession Number:
- 0001415889-24-027224
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-19 16:30:20
- Reporting Period:
- 2024-11-15
- Accepted Time:
- 2024-11-19 16:30:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1845337 | Day One Biopharmaceuticals Inc. | DAWN | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1655962 | Ii N Charles York | 2000 Sierra Point Parkway, Suite 501 Brisbane CA 94005 | Coo, Cfo And Secretary | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-11-15 | 1,375 | $0.00 | 233,860 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-11-15 | 2,250 | $0.00 | 236,110 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-11-15 | 6,625 | $0.00 | 242,735 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-11-18 | 2,602 | $13.21 | 240,133 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Unit (RSU) | Disposition | 2024-11-15 | 1,375 | $0.00 | 1,375 | $0.00 |
| Common Stock | Restricted Stock Unit (RSU) | Disposition | 2024-11-15 | 2,250 | $0.00 | 2,250 | $0.00 |
| Common Stock | Restricted Stock Unit (RSU) | Disposition | 2024-11-15 | 6,625 | $0.00 | 6,625 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 5,500 | No | 4 | M | Direct | ||
| 18,000 | No | 4 | M | Direct | ||
| 79,500 | No | 4 | M | Direct |
Footnotes
- Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock upon settlement for no consideration.
- The sale of shares is for the sole purpose of covering the Reporting Person's tax liability with respect to the settlement of RSUs.
- The price reported in Column 4 is a weighted average price. These shares were sold as part of block trades for multiple security holders of the Issuer at prices ranging from $13.02 to $13.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein with regard to the block trade.
- The RSUs will vest as to 1/16th of the total award in quarterly installments on February 15, May 15, August 15 and November 15, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
- RSUs do not expire; they either vest or are canceled prior to the vesting date.
Billionaire Hedge Funds
